Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study

<b>1. Background:</b> We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tum...

Full description

Bibliographic Details
Main Authors: Muhannad Aboud Abbasi, Giulia Bruno, Cristina Di Stefano, Laura Garcia Bello, Nadia N. Laack, Kimberly S. Corbin, Thomas J. Whitaker, Patricia A. Pellikka, Robert W. Mutter, Hector R. Villarraga
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/10/10/418
_version_ 1827720791486103552
author Muhannad Aboud Abbasi
Giulia Bruno
Cristina Di Stefano
Laura Garcia Bello
Nadia N. Laack
Kimberly S. Corbin
Thomas J. Whitaker
Patricia A. Pellikka
Robert W. Mutter
Hector R. Villarraga
author_facet Muhannad Aboud Abbasi
Giulia Bruno
Cristina Di Stefano
Laura Garcia Bello
Nadia N. Laack
Kimberly S. Corbin
Thomas J. Whitaker
Patricia A. Pellikka
Robert W. Mutter
Hector R. Villarraga
author_sort Muhannad Aboud Abbasi
collection DOAJ
description <b>1. Background:</b> We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. <b>2. Methods:</b> Between March 2016 and March 2017, 70 patients with breast or thoracic cancer were prospectively enrolled and underwent transthoracic echocardiography with comprehensive strain analysis at pretreatment, mid-treatment, end of treatment, and 3 months after RT. <b>3. Results:</b> PBT was used to treat 44 patients; PhT 26 patients. Mean ± SD age was 55 ± 12 years; most patients (93%) were women. The median (interquartile range) of the mean heart dose was lower in the PBT than the PhT group (47 [27–79] vs. 217 [120–596] cGy, respectively; <i>p</i> < 0.001). Ejection fraction did not change in either group. Only the PhT group had reduced systolic tissue Doppler velocities at 3 months. 2D-STE showed changes in endocardial and epicardial longitudinal, radial, and circumferential early diastolic strain rate (SRe) in patients undergoing PhT (global longitudinal SRe, pretreatment vs. end of treatment (<i>p</i> = 0.04); global circumferential SRe, pretreatment vs. at 3-month follow-up (<i>p</i> = 0.003); global radial SRe, pretreatment vs. at 3-month follow-up (<i>p</i> = 0.02) for endocardial values). Epicardial strain values decreased significantly only in patients treated with PhT. Patients in the PhT group had a significant decrease in epicardial global longitudinal systolic strain rate (GLSRs) (epicardial GLSRs, at baseline vs. at end of treatment [<i>p</i> = 0.009]) and in GCSRe and GRSRe (epicardial GCSRe, at baseline vs. at 3-month follow-up (<i>p</i> = 0.02); epicardial GRSRe, at baseline vs. at 3-month follow-up (<i>p</i> = 0.03)) during treatment and follow-up. No changes on 2D-STE were detected in the PBT group. <b>4. Conclusions:</b> Patients who underwent PhT but not PBT had reduced tissue Doppler velocities and SRe values during follow-up, suggesting early myocardial relaxation abnormalities. PBT shows promise as a cardiac-sparing RT technology.
first_indexed 2024-03-10T21:11:18Z
format Article
id doaj.art-f3e9b36b0e494faab4078ba87bbe65f2
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-10T21:11:18Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-f3e9b36b0e494faab4078ba87bbe65f22023-11-19T16:50:41ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252023-10-01101041810.3390/jcdd10100418Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective StudyMuhannad Aboud Abbasi0Giulia Bruno1Cristina Di Stefano2Laura Garcia Bello3Nadia N. Laack4Kimberly S. Corbin5Thomas J. Whitaker6Patricia A. Pellikka7Robert W. Mutter8Hector R. Villarraga9Department of Cardiovascular Medicine Mayo Clinic, Rochester, MN 55905, USAHypertension Unit, Department of Medical Sciences, Città della Salute e della Scienza, University of Torino, 3-10126 Torino, ItalyHypertension Unit, Department of Medical Sciences, Città della Salute e della Scienza, University of Torino, 3-10126 Torino, ItalyDepartment of Cardiovascular Medicine Mayo Clinic, Rochester, MN 55905, USADepartment of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USADepartment of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USADepartment of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USADepartment of Cardiovascular Medicine Mayo Clinic, Rochester, MN 55905, USADepartment of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USADepartment of Cardiovascular Medicine Mayo Clinic, Rochester, MN 55905, USA<b>1. Background:</b> We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. <b>2. Methods:</b> Between March 2016 and March 2017, 70 patients with breast or thoracic cancer were prospectively enrolled and underwent transthoracic echocardiography with comprehensive strain analysis at pretreatment, mid-treatment, end of treatment, and 3 months after RT. <b>3. Results:</b> PBT was used to treat 44 patients; PhT 26 patients. Mean ± SD age was 55 ± 12 years; most patients (93%) were women. The median (interquartile range) of the mean heart dose was lower in the PBT than the PhT group (47 [27–79] vs. 217 [120–596] cGy, respectively; <i>p</i> < 0.001). Ejection fraction did not change in either group. Only the PhT group had reduced systolic tissue Doppler velocities at 3 months. 2D-STE showed changes in endocardial and epicardial longitudinal, radial, and circumferential early diastolic strain rate (SRe) in patients undergoing PhT (global longitudinal SRe, pretreatment vs. end of treatment (<i>p</i> = 0.04); global circumferential SRe, pretreatment vs. at 3-month follow-up (<i>p</i> = 0.003); global radial SRe, pretreatment vs. at 3-month follow-up (<i>p</i> = 0.02) for endocardial values). Epicardial strain values decreased significantly only in patients treated with PhT. Patients in the PhT group had a significant decrease in epicardial global longitudinal systolic strain rate (GLSRs) (epicardial GLSRs, at baseline vs. at end of treatment [<i>p</i> = 0.009]) and in GCSRe and GRSRe (epicardial GCSRe, at baseline vs. at 3-month follow-up (<i>p</i> = 0.02); epicardial GRSRe, at baseline vs. at 3-month follow-up (<i>p</i> = 0.03)) during treatment and follow-up. No changes on 2D-STE were detected in the PBT group. <b>4. Conclusions:</b> Patients who underwent PhT but not PBT had reduced tissue Doppler velocities and SRe values during follow-up, suggesting early myocardial relaxation abnormalities. PBT shows promise as a cardiac-sparing RT technology.https://www.mdpi.com/2308-3425/10/10/418early cardiotoxicityradiotherapystrain rate imagingthoracic cancer
spellingShingle Muhannad Aboud Abbasi
Giulia Bruno
Cristina Di Stefano
Laura Garcia Bello
Nadia N. Laack
Kimberly S. Corbin
Thomas J. Whitaker
Patricia A. Pellikka
Robert W. Mutter
Hector R. Villarraga
Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
Journal of Cardiovascular Development and Disease
early cardiotoxicity
radiotherapy
strain rate imaging
thoracic cancer
title Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_full Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_fullStr Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_full_unstemmed Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_short Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_sort detection of early myocardial dysfunction by imaging biomarkers in cancer patients undergoing photon beam vs proton beam radiotherapy a prospective study
topic early cardiotoxicity
radiotherapy
strain rate imaging
thoracic cancer
url https://www.mdpi.com/2308-3425/10/10/418
work_keys_str_mv AT muhannadaboudabbasi detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT giuliabruno detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT cristinadistefano detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT lauragarciabello detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT nadianlaack detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT kimberlyscorbin detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT thomasjwhitaker detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT patriciaapellikka detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT robertwmutter detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT hectorrvillarraga detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy